News

The cumulative probabilities of treatment initiation after meeting the criteria was not significantly different between the different racial groups and the incidence of major adverse liver outcomes was 0.1 per 100 person-years and did not differ by race.

Leveraging data from more than 40,000 Veterans with primary hyperparathyroidism, a new NIA-funded study details the impact of parathyroidectomy on long-term kidney function among these patients.

New results of a retrospective cohort study showed an important trend with regard to COVID-19 cases and skilled nursing facilities practicing surveillance testing.

Nonoperative management was associated with a 3.72% decrease in the risk of complications and a 1.82% increase in mortality in patients who were aged 65 years and older.

A retrospective analysis of more than 60 patients 21 years or younger who received a transcatheter leadless pacemaker provides an overview of the safety of such an approach in younger patient populations.

Compared with individuals with normal glycemic status, a recent analysis found AMD risk increased with higher glycemic status and longer duration of diabetes.

Compared with nasal masks, oronasal masks are associated with a more collapsible upper airway, requiring higher therapeutic CPAP levels, according to the study.

Announced today by Horizon Therapeutics, the positive and statistically significant data supports the efficacy of teprotumumab across a spectrum of patients with TED regardless of disease activity or duration.

Hyporesponse to erythropoiesis-stimulating agents was associated with increased rates of red blood cell transfusions and poorer outcomes in patients with chronic kidney disease, highlighting the need for alternative anemia treatments.

A prospective study of more than 120 patients who underwent bariatric surgery sheds additional light on the potential benefits incurred by undergoing weight loss surgery in people with obesity.

Acute inpatient admission was higher in patients with persistent hyporesponse, compared to patients with acute hyporesponse or without hyporesponse.

Our latest cardiology case report from Brady Pregerson, MD, features an older man with dementia presenting with hypotension and brought to the hospital with a possible STEMI. Can you determine the correct diagnosis?

The top 10 most popular FDA approval articles from the first quarter of 2023, with an additional spotlight on other top regulatory news from the first 3 months of the year.

The longitudinal study finds prevalent obstructive sleep apnea, insomnia, and sleepiness could differentially mediate or moderate the effect of multiple sclerosis on cognition.

From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.

The investigators found having at least 1 risk factor increased the odds of having an HCV-positive result by 20% compared to the population without risk factors.

A new analysis of OCT biomarkers may help elucidate the utility of OCT biomarkers as therapeutic predictors of ranibizumab treatment among eyes with diabetic macular edema.

New data expands upon the growing perception that allergenic food introduction early in a child’s life may lessen the possibility of allergy developments.

Juliana Reed, MS, believes that there should be legislative incentives and preferred status for lower cost biosimilars in all government programs, with robust competition and accountability for PBMs not to limit access.

An analysis of 3 nationally representative data sets found that SDOH across domains of economic stability, educational attainment, health care access and quality, neighborhood and built environment, and social context were significant predictors of poor vision.

Insomnia shows associations with higher rates of outpatient visits, hospitalizations, and fills for medications, longer hospital length of stay, and higher hospitalization costs.

Juliana Reed, MS, believes that there needs to be action that addresses the anti-competitive behaviors of pharmacy benefit managers (PBMs) and provides access to all biosimilars.

The Gold Standard Pathway Study noted statistically significant reductions in mean IOP and mean medication count from baseline was observed in both treatment arms at all visits.

Results show ISR is a promising behavioral treatment for insomnia, which can reduce sleep latency, increase total sleep time as well as sleep efficiency, and may serve as an alternative to traditional treatments.

April 7, 2023 marks the 75th anniversary of the WHO’s definition of health—a concept that experts point out is yet to be achieved, and faces many modern hurdles.

A retrospective, propensity score-matched analysis details significant risk reductions achieved with bariatric surgery in patients with nonalcoholic fatty liver disease and obesity.

New data from a study in China suggests that practicing tai chi may benefit cognitive function in adults dealing with diabetes as well as cognitive impairment issues.

The March 2023 rheumatology month in review highlights recent data regarding nipocalimab as a treatment option for hemolytic disease of the fetus and newborn and myasthenia gravis, hyperbaric oxygen therapy for fibromyalgia, and the differences among specialties in biosimilar uptake.